Lannett has struck a deal with Chinese respiratory specialist Respirent to gain exclusive US distribution rights to Respirent’s proposed generic version of GlaxoSmithKline’s Advair Diskus (fluticasone/salmeterol).
Lannett Strikes Deal For Respirent’s US Advair Rival
Lannett has struck a deal giving it exclusive US distribution rights for 10 years to a generic version of Advair Diskus being developed by China’s Respirent.
